Vaishakhi Trivedi

Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer

Vanita Noronha, Vijay Patil, Amit Joshi et al. · Journal of Clinical Oncology · 2019 · 415 citations

Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations

Kanika Bajaj Pahuja, Thong Tien Nguyen, Bijay S. Jaiswal et al. · Cancer Cell · 2018 · 159 citations · Full text

Signal Transduction, Protein Transport, Intracellular Trafficking +4

Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

Anuradha Choughule, Rashmi Sharma, Vaishakhi Trivedi et al. · British Journal of Cancer · 2014 · 44 citations · Full text

&lt;p&gt;Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis&lt;/p&gt;

Shruti Kate, Anuradha Chougule, Amit Joshi et al. · Lung Cancer Targets and Therapy · 2019 · 38 citations · Full text

ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes

Amit Joshi, Nikhil Pande, Vanita Noronha et al. · ecancermedicalscience · 2019 · 34 citations · Full text